Bionano Genomics, Inc. (BNGO)

USD 2.79

(-7.92%)

Long Term Debt Summary of Bionano Genomics, Inc.

  • Bionano Genomics, Inc.'s latest annual long term debt in 2023 was 7.17 Million USD , down -21.35% from previous year.
  • Bionano Genomics, Inc.'s latest quarterly long term debt in 2024 Q2 was 5.8 Million USD , down -100.0% from previous quarter.
  • Bionano Genomics, Inc. reported annual long term debt of 9.12 Million USD in 2022, up 2.16% from previous year.
  • Bionano Genomics, Inc. reported annual long term debt of 8.93 Million USD in 2021, down -45.3% from previous year.
  • Bionano Genomics, Inc. reported quarterly long term debt of 6.33 Million USD for 2024 Q1, down -11.78% from previous quarter.
  • Bionano Genomics, Inc. reported quarterly long term debt of 7.68 Million USD for 2023 Q3, down -8.24% from previous quarter.

Annual Long Term Debt Chart of Bionano Genomics, Inc. (2023 - 2016)

Historical Annual Long Term Debt of Bionano Genomics, Inc. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 7.17 Million USD -21.35%
2022 9.12 Million USD 2.16%
2021 8.93 Million USD -45.3%
2020 16.32 Million USD 0.0%
2019 - USD -100.0%
2018 9.02 Million USD 0.0%
2017 - USD -100.0%
2016 6.04 Million USD 0.0%

Peer Long Term Debt Comparison of Bionano Genomics, Inc.

Name Long Term Debt Long Term Debt Difference
bioAffinity Technologies, Inc. 1.11 Million USD -541.502%
Aspira Women's Health Inc. 1.43 Million USD -401.748%
Castle Biosciences, Inc. 14.19 Million USD 49.465%
Exact Sciences Corporation 2.47 Billion USD 99.71%
IDEXX Laboratories, Inc. 622.88 Million USD 98.848%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -8722.734%
iSpecimen Inc. 29.13 Thousand USD -24530.965%
Standard BioTools Inc. 3.98 Million USD -80.141%
Inotiv, Inc. 399.4 Million USD 98.204%
Psychemedics Corporation 945 Thousand USD -659.259%
Prenetics Global Limited 867.21 Thousand USD -727.361%
RadNet, Inc. 812.06 Million USD 99.116%
Star Equity Holdings, Inc. 1.14 Million USD -526.638%
Neuronetics, Inc. 59.28 Million USD 87.897%
OpGen, Inc. 2.02 Million USD -254.914%
Exagen Inc. 19.23 Million USD 62.69%
CareDx, Inc 28.27 Million USD 74.627%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 79.17 Million USD 90.938%
Guardant Health, Inc. 1.13 Billion USD 99.371%
Biodesix, Inc. 35.22 Million USD 79.631%
BioNexus Gene Lab Corp. 98.76 Thousand USD -7164.866%
Precipio, Inc. 106 Thousand USD -6668.868%
Natera, Inc. 282.94 Million USD 97.464%
Fulgent Genetics, Inc. 10.11 Million USD 29.038%
Sera Prognostics, Inc. 840 Thousand USD -754.167%
23andMe Holding Co. 67.84 Million USD 89.424%
OPKO Health, Inc. 222.03 Million USD 96.769%
Personalis, Inc. 1.23 Million USD -481.442%
Aclaris Therapeutics, Inc. 3.07 Million USD -133.409%
Applied DNA Sciences, Inc. 739.16 Thousand USD -870.694%
T2 Biosystems, Inc. 6.59 Million USD -8.745%
Neogen Corporation 888.39 Million USD 99.192%
Myriad Genetics, Inc. 130.9 Million USD 94.519%
ICON Public Limited Company 3.66 Billion USD 99.804%
NeoGenomics, Inc. 606.06 Million USD 98.816%
Star Equity Holdings, Inc. 1.14 Million USD -526.638%
MDxHealth SA 35.56 Million USD 79.825%
Prenetics Global Limited 867.21 Thousand USD -727.361%
Illumina, Inc. 1.48 Billion USD 99.518%
DarioHealth Corp. 24.59 Million USD 70.823%
ENDRA Life Sciences Inc. 192.06 Thousand USD -3635.773%
Medpace Holdings, Inc. 142.12 Million USD 94.952%
Mainz Biomed B.V. 2.19 Million USD -226.747%
Trinity Biotech plc 54.65 Million USD 86.871%
Sotera Health Company 2.22 Billion USD 99.677%
bioAffinity Technologies, Inc. 1.11 Million USD -541.502%